At Anthea Pharma, we are gearing up to support our partners with the manufacturing of GLP-1 — one of the most technically challenging and globally in-demand molecules today.

This reflects our growing strength and readiness in:

• High-complexity peptide formulations
• Advanced R&D and analytical development capabilities
• End-to-end CDMO solutions from clinical to commercial scale

With global demand for GLP-1 therapies at an all-time high, Anthea Pharma is committed to being the partner of choice for companies seeking Quality, Speed, and Reliability in complex injectables with its state-of-the-art USFDA-approved injectables manufacturing facility.